drug target identification using side-effect similarity
targets drugs far predicted basis molecular cellular features example exploiting similarity chemical structure activity across cell lines used phenotypic side effect similarities infer whether two drugs share target applied marketed drugs network side effect driven drug drug relations became apparent formed chemically dissimilar drugs different therapeutic indications experimentally tested unexpected drug drug relations validated implied drug target relations vitro binding assays reveal inhibition constants equal less micromolar nine tested confirmed cell assays documenting feasibility using phenotypic information infer molecular interactions hinting new uses marketed drugs
